Electroconvulsive Therapy

Mechanism

Related News

Brain Imaging and Precision Medicine Advance Treatment-Resistant Depression Therapies

Mar 14, 2026

New research reveals how ketamine rewires brain receptors to rapidly relieve severe depression, while separate trials demonstrate success with personalized brain stimulation and targeted drug therapy for treatment-resistant cases.

Cyclerion Receives Positive FDA Feedback on CYC-126 Phase 2 Study for Treatment-Resistant Depression

Feb 17, 2026

Cyclerion Therapeutics received positive FDA feedback on its Phase 2 study design for CYC-126, an anesthetic-based therapy with real-time EEG monitoring for treatment-resistant depression, with study initiation planned for second half of 2026.